Pacific Biosciences Of California | PACB - Cost Of Sales


Pacific Biosciences Of California reported $28.9M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 845M 7M Mar/2026
Bruker USD 422.5M 21.1M Jun/2026
Danaher USD 2.65B 294M Jun/2026
General Electric Aerospace USD 8.89B 736M Jun/2026
Illumina USD 389M 19M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quidel USD 407M 486.5M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Standard Biotools USD 9.84M 2.58M Mar/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Waters USD 1.16B 430M Jun/2026